| Not Yet Recruiting | Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases Breast Cancer, HER2-positive Breast Cancer, Brain Metastases | Phase 1 | 2026-06-01 |
| Not Yet Recruiting | Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolas Prostate Cancer, Localized Prostate Carcinoma | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | MucoLock™ for Treatment of Stomatitis Stomatitis, Pain, Burning Mouth | N/A | 2026-04-01 |
| Enrolling By Invitation | Nurse Caring Communication Engagement Perceptions of Caring, Hospital Readmissions | N/A | 2026-02-15 |
| Enrolling By Invitation | Impact of Immersive Video Education on Cardiothoracic Surgery Anxiety and Outcomes Anxiety | N/A | 2026-01-15 |
| Recruiting | Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Gliobla Glioblastoma, Brain Cancer, Glioblastoma Multiforme | Phase 2 | 2025-12-03 |
| Enrolling By Invitation | Exploring the Effect of Aromatherapy Anxiety, Labor Pain, Nausea and Vomiting | N/A | 2025-10-15 |
| Recruiting | PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial Glioma, Glioma, Malignant, Recurrent Glioma | N/A | 2025-04-30 |
| Recruiting | Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue Glioblastoma, Glioblastoma Multiforme, Gliosarcoma | — | 2024-12-11 |
| Withdrawn | 177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | 2024-10-01 |
| Active Not Recruiting | Ablative Stereotactic MR-Guided Adaptive Reirradiation Abdominal Cancer, Pelvic Cancer | N/A | 2024-06-05 |
| Recruiting | Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) L Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma, Relapsed Cancer | Phase 2 | 2024-04-25 |
| Recruiting | 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery Brain Metastases, Brain Metastases, Adult, Brain Cancer | Phase 1 | 2024-04-11 |
| Terminated | Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer Brain Metastases, HER2-positive Breast Cancer | Phase 1 | 2024-01-29 |
| Recruiting | Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases Cancer, Metastasis, Metastatic Cancer | Phase 1 / Phase 2 | 2023-11-17 |
| Recruiting | Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma | N/A | 2023-09-21 |
| Withdrawn | Cemiplimab/Peg-Interferon-α in Advanced CSCC Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma | Phase 1 | 2023-07-01 |
| Recruiting | ZYNRELEF for Pain Management in Total Knee Arthroplasty Post Operative Pain, Osteoarthritis, Knee | Phase 4 | 2023-03-09 |
| Recruiting | Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis Brain Metastases, Brain Cancer | Phase 2 | 2023-01-10 |
| Withdrawn | CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia | Phase 2 | 2022-09-01 |
| Recruiting | Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease Spine Metastases | Phase 1 / Phase 2 | 2022-08-29 |
| Recruiting | Cabozantinib for Patients With Recurrent or Progressive Meningioma Meningioma | Phase 2 | 2022-06-01 |
| Withdrawn | Study of LUNG Stereotactic Adaptive Ablative Radiotherapy Lung Cancer, Lung Tumor | N/A | 2022-05-02 |
| Recruiting | Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radio Brain Metastases, Adult, Brain Metastases, Brain Cancer | Phase 1 | 2022-04-04 |
| Withdrawn | Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malign B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma | Phase 2 | 2022-03-28 |
| Recruiting | Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic Neurocognitive Disorders | — | 2021-11-30 |
| Completed | Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction Metastatic Carcinoma | N/A | 2021-06-18 |
| Recruiting | Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column Spine Metastases, Metastasis Spine | N/A | 2021-03-14 |
| Terminated | Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19) Covid19 | Phase 1 / Phase 2 | 2020-12-23 |
| Terminated | Pembrolizumab and Olaparib in Cervical Cancer Patients Cervical Cancer, Cervical Carcinoma | Phase 2 | 2020-12-03 |
| Active Not Recruiting | Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation Oncology, Spine Metastases | N/A | 2020-05-22 |
| Terminated | Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma. Metastatic Carcinoma | N/A | 2020-04-08 |
| Withdrawn | Using EEG to Predict Depression Treatment Response to rTMS in Patients With Major Depression Major Depression, Repetitive Transcranial Magnetic Stimulation | — | 2020-04-01 |
| Active Not Recruiting | Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors. Brain Tumor, Brain Cancer, Skull Base Tumor | — | 2019-03-08 |
| Terminated | Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Gliobl Recurrent Glioblastoma | Phase 2 | 2018-12-05 |
| Terminated | Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas Adenocarcinoma of the Pancreas | Phase 2 | 2018-11-09 |
| Completed | Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors Solid Tumor, Adult | Phase 2 | 2017-11-03 |
| Terminated | Repeated TMS at Low Frequencies to Reduce Seizure Occurrence Epilepsy, Status Epilepticus, Epilepsia Partialis Continua | N/A | 2016-02-19 |
| Completed | Acute Chest Pain Imaging in the ED With the Combine CCTA and CT Perfusion Chest Pain | — | 2015-09-01 |
| Active Not Recruiting | The Miami Heart Study at Baptist Health South Florida Cardiovascular Disease | — | 2015-05-01 |
| Terminated | South Miami Hospital Fibroid Registry Uterine Myomas, Leiomyomas, or Fibromas | — | 2015-02-01 |
| Terminated | The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis Hypokalemia | Phase 4 | 2014-02-25 |
| Completed | A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancer Weight | N/A | 2013-09-01 |
| Completed | A Web-based Approach to Treating Cardiovascular Disease Risk in Employees With Metabolic Syndrome Metabolic Syndrome, Cardiovascular Disease, Atherosclerosis | N/A | 2013-08-01 |
| Completed | Electroencephalogram (EEG) Triggered Functional Magnetic Resonance Imaging (fMRI) in Epilepsy Patients Epilepsy | N/A | 2013-02-01 |
| Completed | Radioprotective Light-weight Caps in the Interventional Cardiology Setting Occupational Exposure to Radiation | N/A | 2012-08-01 |
| Recruiting | Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms Thoracoabdominal Aortic Aneurysm, Aortic Arch Aneurysm | N/A | 2012-01-25 |
| Withdrawn | Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial) Chronic Kidney Disease | — | 2011-09-01 |
| Completed | New Fabric Attenuation Device in Endovascular Interventional Radiology (PREFER) Exposure | — | 2011-09-01 |
| Completed | New Fabric Attenuation Device in Endovascular Interventional Radiology II (PREFER II) Occupational Exposure to Radiation | N/A | 2011-05-01 |
| Unknown | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer | Phase 2 | 2000-03-01 |